FierceBiotechOriginal article
{"a":[{"_":"Natera teams with Angiex on cancer drug trial monitoring","$":{"href":"/medtech/natera-teams-angiex-advance-its-signatera-cancer-dx-tool","hreflang":"en"}}]}
PartnershipSignateraPositive
AI Analysis
Summary
Natera announced a collaboration with Angiex to assess the use of its Signatera blood test for monitoring cancer DNA in treated patients. The partnership aims to advance the clinical application of Natera's cancer diagnostic tool.
Importance:5/10
Sentiment:
0.40
partnershipcollaborationdiagnosticscancerliquid biopsy
Related Companies
Read the original article
Published by FierceBiotech on August 31, 2026 7:44 AM
